Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Axonics Modulation Technologies Inc.

www.axonicsmodulation.com

Latest From Axonics Modulation Technologies Inc.

FDA Approves Axonics’ Neuromodulation Device For Incontinence

The US FDA has approved r-SNM sacral neuromodulation system for treating chronic fecal incontinence and Axonics expects the agency to approve it for overactive bladder and urinary retention in the next few weeks. The company expects r-SNM to compete with Medtronic's Interstim non-rechargeable sacral neuromodulation system.

Approvals Clinical Trials

Global Device Approvals, Weekly Snapshot: Biotronik, Edwards And Bioness Make Waves

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, a noteworthy stent approval, and advancements in mitral valve repair and neurostim for urology.

Approvals Research & Development

Axonics Appoints Chief Medical Officer

Former chief medical officer at the University of California, Karen Noblett, has been named as the CMO of neuromodulation technology company Axonics.

Appointments Medical Device

Hindsight 20/20: Raymond Cohen

Hindsight 20/20 is a new Q&A feature where medtech industry veterans share their long experience taking diverse businesses – be they start-ups or publicly-listed entities – from strength to strength and navigating through times of crises. This first instalment shines the spotlight on Raymond Cohen, who is currently CEO of venture-backed sacral neuromodulation company Axonics Modulation Technologies, Inc. The advice he gives includes not rushing into clinical studies too soon, try to go big with the fundraising and be very cautious when tackling a complex market like the US, among other things.

Business Strategies Hindsight 20/20
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Gynecological, Urological
  • Neurology, Nervous System
  • Alias(es)
  • American Restorative Medicine Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Axonics Modulation Technologies Inc.
  • Senior Management
  • Raymond W Cohen, CEO
    Dan L Dearen, COO & CFO
    Jiang Guangqiang, PhD, CTO
    Emilie Finiels, Senior Dir., Bus. Dev.
    John Woock, PhD, VP, Global Mktg. & Clinical Operations
    Karen L Noblett, MD, CMO
  • Contact Info
  • Axonics Modulation Technologies Inc.
    Phone: (949) 396-6322
    7575 Irvine Center Dr.
    Ste. 200
    Irvine, CA 92618
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register